NCT07334119 2026-02-19Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid TumorsMyeloid TherapeuticsPhase 1 Recruiting60 enrolled
NCT05150691 2026-01-28A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsDualityBio Inc.Phase 1/2 Recruiting796 enrolled
NCT05194072 2026-01-09A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid TumorsSeagen Inc.Phase 1 Terminated250 enrolled
NCT06399757 2026-01-07A Study to Investigate APL-5125 in Adults With Advanced Solid TumorsApollo Therapeutics LtdPhase 1/2 Recruiting100 enrolled
NCT07319767 2026-01-06Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant TumorsShanghai Zhongshan HospitalCompleted120 enrolled